Does metabolic syndrome influence bioprosthetic mitral valve degeneration and reoperation rate?

Journal of Cardiac Surgery

Volumn 27, Issue 2, 2012, Pages 146-151

  Meyer, Steven R ^a   Suri, Rakesh M ^b   Wright, R Scott ^b   Dearani, Joseph A ^b   Orszulak, Thomas A ^b   Daly, Richard C ^b   Burkhart, Harold M ^b   Park, Soon J ^b   Schaff, Hartzell V ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CALCIFICATION; CONTROLLED STUDY; DISEASE COURSE; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART VALVE BIOPROSTHESIS; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; OVERALL SURVIVAL; PROSTHETIC VALVE DYSFUNCTION; REOPERATION; RHEUMATIC DISEASE; STENOSIS;

AGED; AGED, 80 AND OVER; BIOPROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MITRAL VALVE; PROSTHESIS FAILURE; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859388959     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2011.01412.x     Document Type: Article

References (17)

1. Hammermeister K, Sethi GK, Henderson WG, et al: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-1158.
2. Manji RA, Zhu LF, Nijjar NK, et al: Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006;114:318-327. (Pubitemid 44297098)
3. Farivar RS, Cohn LH: Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003;126:969-975.
4. Nollert G, Miksch J, Kreuzer E, et al: Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 2003;126:965-968. (Pubitemid 37305676)
5. Grundy SM: Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093-1100.
6. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
7. Briand M, Lemieux I, Dumesnil JG, et al: Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006;47:2229-2236. (Pubitemid 43795081)
8. Briand M, Pibarot P, Despres JP, et al: Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 2006;114:I512-1517.
9. Edmunds LH, Jr., Clark RE, Cohn LH, et al: Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711.
10. Vyavahare N, Ogle M, Schoen FJ, et al: Mechanisms of bioprosthetic heart valve failure: Fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999;46:44-50. (Pubitemid 29233179)
11. Milano A, Bortolotti U, Talenti E, et al: Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol 1984;53:1066-1070. (Pubitemid 14174253)
12. Schoen FJ, Levy RJ: Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080. (Pubitemid 40288798)
13. Valente M, Bortolotti U, Thiene G: Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21. 14. Valente M, Pettenazzo E, Thiene G, et al: Detoxified glutaraldehyde cross-linked pericardium: Tissue preservation and mineralization mitigation in a subcutaneous rat model. J Heart Valve Dis 1998;7:283-291. (Pubitemid 28266849)
14. Price L, Sniderman A, Omerglu A, et al: Bioprosthetic valve degeneration due to cholesterol deposition in a patient with normal lipid profile. Can J Cardiol 2007;23:233-234. (Pubitemid 46736380)
15. David TE, Ivanov J: Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thorac Cardiovasc Surg 2003;126:939-941. (Pubitemid 37305670)
16. Bellamy MF, Pellikka PA, Klarich KW, et al: Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-1730. (Pubitemid 35341948)
17. Antonini-Canterin F, Zuppiroli A, Popescu BA, et al: Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003;92:1479-1482. (Pubitemid 37532579)